U.S. Markets close in 11 mins.

Acasti Pharma Inc. (ACST)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.240.00 (0.00%)
As of 3:46PM EDT. Market open.
People also watch
NEPTAKERBSPMCLRBAPRI
Interactive chart
Previous Close1.24
Open1.25
Bid1.24 x 200
Ask1.25 x 300
Day's Range1.24 - 1.25
52 Week Range1.11 - 3.09
Volume22,324
Avg. Volume66,070
Market Cap18.81M
BetaN/A
PE Ratio (TTM)-1.85
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q3, 2017 By the Numbers : January 16, 2017
    Capital Cube4 months ago

    Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q3, 2017 By the Numbers : January 16, 2017

    Categories: Yahoo Finance Get free summary analysis Acasti Pharma, Inc. reports financial results for the quarter ended November 30, 2016. Highlights Summary numbers: Revenues of USD 0.00 million, Net Earnings of USD -1.81 million. Gross margins narrowed from -11,793.42% to -49,227.19% compared to the same period last year, operating (EBITDA) margins now -152,239.51% from -40,336.32%. Change in operating ... Read more (Read more...)

  • Associated Press4 months ago

    Acasti reports 3Q loss

    On a per-share basis, the Laval, Quebec-based company said it had a loss of 17 cents. The biopharmaceutical company posted revenue of $900 in the period. Its adjusted revenue was $1,000. In the final minutes ...

  • Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q2, 2017 By the Numbers : October 14, 2016
    Capital Cube7 months ago

    Acasti Pharma, Inc. :ACST-US: Earnings Analysis: Q2, 2017 By the Numbers : October 14, 2016

    Categories: Yahoo Finance Get free summary analysis Acasti Pharma, Inc. reports financial results for the quarter ended August 31, 2016. Highlights Summary numbers: Revenues of USD 0.00 million, Net Earnings of USD -1.80 million. Gross margins narrowed from -8,428.98% to -16,725.14% compared to the same period last year, operating (EBITDA) margins now -50,933.99% from -22,593.98%. Change in operating ... Read more (Read more...)